07:00 , Mar 10, 2014 |  BC Week In Review  |  Company News

diaDexus, Thermo Fisher deal

Thermo Fisher granted diaDexus exclusive rights to develop and commercialize diagnostic clinical laboratory tests in the U.S. based on three biomarkers from Thermo Fisher to aid in risk prediction and prognosis for heart failure. The...
07:00 , Jul 25, 2011 |  BC Week In Review  |  Company News

Alere, Thermo Fisher deal

Alere received worldwide rights to integrate Thermo Fisher's B.R.A.H.M.S. biomarkers on Alere's point-of-care Triage diagnostic tests. Triage is a rapid immunoassay that measures biomarkers in blood, plasma and urine. Biomarkers to be integrated include Procalcitonin...